Predictive Genetic Counselling Market Research Reveals Strong 15.9% CAGR Outlook Through 2030

The predictive genetic counselling sector is gaining significant traction as personalized medicine advances and genomics become integral to healthcare. With rising technological adoption and patient awareness, the market is positioned for impressive growth, driven by innovations and expanding service offerings that cater to preventive and precision medicine.

Projected Growth of the Predictive Genetic Counselling Market by 2030
The market for predictive genetic counselling is anticipated to expand swiftly, reaching a valuation of $8.79 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 15.9%. Factors propelling this expansion include the growing incorporation of genomics into everyday healthcare practices, increased use of virtual counselling platforms, wider implementation of preventive screening programs, and enhanced AI-driven genetic interpretation methods. Furthermore, there is a rising demand for personalized health risk information. Emerging trends during the forecast period also feature a surge in online genetic counselling services, widespread adoption of polygenic risk scores, growth in direct-to-consumer genetic testing, expansion of predictive oncology counselling, and greater emphasis on patient education and clinical decision support.

The predictive genetic counselling market size has grown rapidly in recent years. It will grow from $4.19 billion in 2025 to $4.87 billion in 2026 at a compound annual growth rate (CAGR) of 16.2%. The growth in the historic period can be attributed to increasing utilization of family history evaluation, expansion of cancer risk screening programs, growing acceptance of genetic testing, improvements in counseling methodologies, rising public awareness of inherited diseases.

Download a free sample of the predictive genetic counselling market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27397&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Industry Players Dominating the Predictive Genetic Counselling Market
Notable companies shaping the predictive genetic counselling landscape comprise Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, 23andMe Holding Co., Color Genomics Inc., deCODE genetics, Centogene NV, Admera Health LLC, Mapmygenome, Exact Sciences Corporation, and BGI Group.
A significant development occurred in February 2025 when Tempus AI, Inc., a US-based firm specializing in AI-enabled precision medicine and diagnostics, acquired Ambry Genetics for $600 million. This acquisition allows Tempus AI to leverage Ambry's established genetic-testing infrastructure, expertise in variant interpretation, and extensive hereditary-risk testing portfolio. It strengthens Tempus AI's genomic diagnostic capabilities while enhancing operational scale, clinical testing reach, and service delivery. Ambry Genetics is renowned for its focus on hereditary cancer screening, rare-disease testing, and advanced variant interpretation services.

Emerging Trends Influencing the Predictive Genetic Counselling Market
Leading companies in the predictive genetic counselling space are dedicating efforts to the development of sophisticated predictive genetic testing services that enable early disease risk detection and assist in informed clinical decision-making. Predictive genetic testing involves analyzing an individual's DNA to detect genetic variations linked to an elevated risk of inherited conditions or diseases.
For example, in August 2024, Australia-based Genetic Technologies Limited introduced the geneType Risk Assessment test. This comprehensive, multi-risk predictive genetic screening tool evaluates an individual's probability of developing major diseases such as breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease, and type 2 diabetes. It combines clinically validated polygenic risk scores with non-genetic factors-including age, family history, and clinical measurements-to provide a personalized and actionable risk profile. Available in over 42 countries, the test is designed for proactive health management and offers clear reports with tailored recommendations to support preventive care and lifestyle choices.

View the full predictive genetic counselling market report:
https://www.thebusinessresearchcompany.com/report/predictive-genetic-counselling-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Breakdown of Market Segments in the Global Predictive Genetic Counselling Industry
The global predictive genetic counselling market is segmented across several dimensions:
1) Service Type: Risk Assessment, Carrier Testing, Predictive Testing, Other Services
2) Delivery Mode: In-Person, Online
3) Application Areas: Consumer Genomics, Breast and Ovarian Cancer, Cardiovascular Screening, Diabetic Screening and Monitoring, Colon Cancer, Parkinsonism or Alzheimer's Disease, Urologic Screening or Prostate Cancer Screening, Orthopedic and Musculoskeletal, Other Applications
4) End-Users: Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, Other End-Users
Subcategories include:
- Risk Assessment: Family History Evaluation, Lifestyle and Environmental Risk Analysis, Polygenic Risk Score Analysis, Hereditary Disease Susceptibility Screening
- Carrier Testing: Cystic Fibrosis Carrier Testing, Tay-Sachs Carrier Testing, Fragile X Syndrome Testing, Sickle Cell Carrier Testing, Thalassemia Carrier Screening
- Predictive Testing: BRCA1 or BRCA2 Mutation Testing, Lynch Syndrome Testing, Huntington's Disease Testing, Cardiovascular Genetic Risk Testing, Neurological Disorder Prediction Testing
- Other Services: Pharmacogenomic Testing, Prenatal Genetic Testing, Newborn Genetic Screening, Direct-to-Consumer Genetic Testing, Whole Genome Sequencing for Prediction

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.